1. "CTCR Scholars"
Formats
  1. Meeting Abstract (846)
  2. Journal Article (546)
  3. Review (68)
  4. Research Letter (35)
  5. Editorial (29)
  6. Correspondence (24)
  7. Miscellaneous (16)
  8. Book Section (10)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. CTCR Scholars (1585)
  2. Department of Medicine (1369)
  3. Hematologic Malignancies, Division of (1045)
  4. MSK Grad Students (989)
  5. Master of Science in Clinical and Translational Cancer Research (956)
  6. Center for Hematologic Malignancies (955)

More Groups

People
  1. Sergio Giralt (539)
  2. Miguel-Angel Perales (397)
  3. Michael Scordo (366)
  4. Gunjan Shah (321)
  5. Sean Devlin (321)
  6. Parastoo Dahi (294)

More People

Years
  1. 2025 (68)
  2. 2024 (227)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (294)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (140)
  4. Annals of Surgical Oncology (81)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (55)

More Publications

Publishers
  1. Elsevier Inc. (390)
  2. American Society of Hematology (345)
  3. American Society of Clinical Oncology (153)
  4. Nature Publishing Group (130)
  5. Springer (98)
  6. American Association for Cancer Research (65)

More Publishers

Results (1585)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Salvage hepatic artery infusion chemotherapy after first-line systemic failure in patients with unresectable cholangiocarcinoma
    Meeting Abstract

    Nasar, N.; Armstrong, M.; Chou, J. F.; Gonen, M.; Soares, K.; Balachandran, V. P.; Drebin, J. A.; Kingham, T. P.; Wei, A. C. C.; D'Angelica, M. I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Extrahepatic cholangiocarcinoma: Genomic variables associated with anatomical location and outcome
    Meeting Abstract

    Preston, W. A.; Drill, E. N.; Boerner, T.; Harding, J. J.; Cercek, A.; O'Reilly, E. M.; Abou-Alfa, G. K.; Park, W.; Balachandran, V. P.; Drebin, J. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Patient-derived biliary tract cancer organoid biobank: Is personalized medicine utilizing organoids feasible for patients with cholangiocarcinoma?
    Meeting Abstract

    Nasar, N.; McIntyre, S. M. H.; Kalvin, H. L.; Gonen, M.; Lecomte, N.; Karnoub, E.; Hong, J.; Soares, K.; Balachandran, V. P.; Drebin, J. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Has management of locally advanced intrahepatic cholangiocarcinoma evolved with the evidence? Trends and practice patterns from the National Cancer Database
    Meeting Abstract

    Schleimer, L. E.; Kalvin, H. L.; Kingham, T. P.; Soares, K.; D'Angelica, M. I.; Balachandran, V. P.; Drebin, J. A.; Cercek, A.; Abou-Alfa, G. K.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of LY3537982, a potent and highly selective KRAS G12C inhibitor in KRAS G12C-mutant GI cancers: Results from a phase 1 study
    Meeting Abstract

    Hollebecque, A.; Kuboki, Y.; Murciano-Goroff, Y. R.; Yaeger, R.; Cassier, P. A.; Heist, R. S.; Fujiwara, Y.; Deming, D. A.; Ammakkanavar, N.; Patnaik, A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intrahepatic cholangiocarcinoma: Recurrence patterns, genomics and survival
    Meeting Abstract

    Chandra, P.; Song, Y.; Drill, E. N.; Wei, A. C. C.; Kemeny, N. E.; Cercek, A.; Connell, L. C.; Harding, J. J.; Abou-Alfa, G. K.; Park, W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Concordance in oncogenic alterations between the primary tumor and advanced disease: Insights into the heterogeneity of intrahepatic cholangiocarcinoma
    Journal Article

    McIntyre, S. M.; Preston, W. A.; Walch, H.; Sharib, J.; Kundra, R.; Sigel, C.; Lidsky, M. E.; Allen, P. J.; Morse, M. A.; Chen, W.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Subsequent malignancies after CD19-targeted chimeric antigen receptor T cells in patients with lymphoma
    Journal Article

    Lorenc, R.; Shouval, R.; Flynn, J. R.; Devlin, S. M.; Saldia, A.; Luna De Abia, A.; De Lapuerta, M. C.; Tomas, A. A.; Cassanello, G.; Leslie, L. A.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Dermatologic adverse events associated with chimeric antigen receptor T-cell therapy: A pharmacovigilance analysis of the FDA Reporting System
    Journal Article

    Storgard, R.; Dusza, S.; Shouval, R.; Scordo, M.; Markova, A.
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • In pursuit of optimal outcomes: A framework for quality standards in immune effector cell therapy
    Editorial

    Dandoy, C. E.; Adams, J.; Artz, A.; Bredeson, C.; Dahi, P. B.; Dodd, T.; Jaglowski, S.; Lehmann, L.; LeMaistre, C. F.; Mian, A.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save